America’s national security defenses are in a “state of disrepair” and the rapid rise in extremist cases across the country ...

Danaher Co. (NYSE:DHR – Free Report) – Stock analysts at William Blair decreased their Q3 2025 earnings per share estimates for Danaher in a note issued to investors on Monday, January 13th.

Danaher Trading Down 1.4 % Shares of DHR opened at $238.41 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a market ...

As of 2025-01-17, Danaher Corp's intrinsic value as calculated by the Discounted Earnings model is $131.19. It's currently trading at a price of $241.9. Therefore, the margin of safety based on ...

The Justice Department released special counsel Jack Smith's final report on his investigation into Donald Trump's 2020 election interference efforts. Trump faced four charges: conspiracy to ...

Shares of Danaher Corp. DHR slipped 1.46% to $238.36 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.00% to 5,996.66 ...

Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.21% to 5,937.34 ...

I spent much of the past two years following and applauding the efforts of special counsel Jack Smith to bring Donald Trump to book. But I am coming around to agreeing with Trump that Smith is a ...

It’s a state of affairs in which Attorney General Merrick Garland playing it by the book will effectively aid Trump’s bid to keep special counsel Jack Smith’s report on the documents case under wraps.

Jack Royston is Newsweek's Chief Royal Correspondent based in London, U.K. He reports on the British royal family—including King Charles III, Prince William, Kate Middleton, Prince Harry and ...

Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...